It’s More Than a Career, It’s a Mission.
Our people are the foundation of our success. By joining our growing team at Sarah Cannon Research Institute (SCRI), a subsidiary of McKesson, you will have the opportunity to become part of one of the largest community-based cancer programs to advance oncology treatments and improve outcomes for cancer patients across the globe. We look for mission-driven candidates who have a desire to advance the fight against cancer and make a difference in the lives of patients diagnosed with cancer every day.
Our Mission
People who live with cancer – those who work to prevent it, fight it, and survive it – are at the heart of every decision we make. Bringing the most innovative medical minds together with the most passionate caregivers in their communities, we are transforming care and personalizing treatment. Through clinical excellence and cutting-edge research, SCRI is redefining cancer care around the world.
As the Study Activation Specialist you are responsible for managing the startup activities of clinical trials proposed and entering those trials into the Sarah Cannon Strategic Sites’ clinical research program menus. You will maintain relationships and facilitate progress across multiple groups including but not limited to internal SC departments, Strategic Sites physicians and staff, Contract Research Organizations (CROs), and Pharmaceutical Companies. You will serve as the primary responsible party and point of contact during clinical research trial feasibility, planning, and implementation stages up until the point of site activation.
You will develop relationships with sponsors and (CROs), which provide potential studies
You will maintain a database of potential pharmaceutical and CRO relationships
You will market Sarah Cannon services and capabilities to pharmaceutical companies, CROs and within the industry network
You will develop and maintain strong industry ties, utilizing both the network and the Internet, in order toacquirenew studies
You will provide information and updates on current studies in the start-up process at all Sponsor meetings
You will track all site metrics relating to the study start up process for each Strategic Site
You will track and report statistics on Strategic Site accrual and overall performance history
You will coordinate and lead Protocol Review Committee Meeting; You will update and distribute Protocol Review meeting agenda and reports
You will coordinate and lead individual Strategic Site Operation Meetings; You will update and distribute reports for Strategic Site Operation Meetings
You will create and update all Strategic Site pages, including uploading study documents and creating study folders within Strategic Site pages
You will intercede as needed to facilitate Site to Sponsor communication during pre-study phase
You will attend tumor program meetings with Principal Investigators and provide updates on study status during meetings
You will maintain updated Site List and Contact Information and distribute updated list to corporate staff
You will ensure all CDAs, Questionnaires, and Pre-study Site Visit Follow-up Forms are accurately tracked for completion
You will create, update, and distribute Key Studies Reports bi-weekly within the company
You will create, update, and distribute Clinical Trial Reviews monthly for specified Strategic Sites
You will monitor specific progress and industry trends relevant to SC Research Operations and participates in educational activities and programs as directed by SC Principal Investigators or other senior management
You should have for this position:
A High School Diploma; Bachelor Degree preferred
Knowledge of pharmaceutical industry, regulatory processes, clinical trials and medical terminology
The availability to travel occasionally
At least one year of experience in Customer Service in a Client Facing Role
Experience in healthcare or marketing
Interested candidates should submit their application through https://www.scri.com/careers/. Applications will be accepted through October 13, 2025. Please ensure all required materials are included as outlined in the posting.
About Sarah Cannon Research Institute
Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. In 2022, SCRI formed a joint venture with former US Oncology Research to expand clinical trial access across the country. It has conducted more than 750 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA today. SCRI’s research network brings together more than 1,300 physicians who are actively enrolling patients into clinical trials at more than 250 locations in 24 states across the U.S. Please click here to learn more about our research offerings.
We care about the well-being of the patients and communities we serve, and that starts with caring for our people. That’s why we have a Total Rewards package that includes comprehensive benefits to support physical, mental, and financial well-being. Our Total Rewards offerings serve the different needs of our diverse colleague population and ensure they are the healthiest versions of themselves. For more information regarding benefits through our parent company, McKesson, please click here.
As part of Total Rewards, we are proud to offer a competitive compensation package. This is determined by several factors, including performance, experience and skills, equity, regular job market evaluations, and geographical markets. In addition to base pay, other compensation, such as an annual bonus or long-term incentive opportunities may be offered.
We are an equal opportunity employer and value diversity at our company. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.
